Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)

Authors

Keywords

Journal

Volume 100, Issue 2, Pages 215-217

Publisher

Wiley

Online

2017-10-24

DOI

10.1111/ejh.12986

References

View 5 related references

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now